ALCIDION GROUP LIMITED — Capital/Financing Update 2021

Dec 28, 2021

29 December 2021

==> picture [157 x 42] intentionally omitted <==

Australian Securities Exchange 20 Bridge Street, Sydney NSW 2000

Alcidion completes Retail Entitlement Offer

Melbourne, Australia – Alcidion Group Limited ( Alcidion or the Company ) is pleased to announce the completion of the retail component of its 1 for 10.5 accelerated non‐renounceable entitlement offer ( Entitlement Offer ) of new shares in Alcidion ( New Shares ), details of which were announced to the ASX on Tuesday, 14 December 2021.

The retail component of the Entitlement Offer ( Retail Entitlement Offer ) closed at 5.00pm (Sydney time) on Thursday, 23 December 2021 and raised a total of approximately A$11.6M. The total amount raised under the placement and Entitlement Offer is approximately A$55.0M.

The Retail Entitlement Offer received a total of 1,925 valid applications for retail entitlements which included over subscriptions up to 100% of an eligible shareholders entitlement. Approved valid applications were received for approximately 18.7 million New Shares equating to approximately $4.7M, representing a take up rate by eligible retail shareholders of approximately 40%.

The approximately 27.6 million New Shares that were not taken up by eligible retail shareholders under the Retail Entitlement Offer will be allotted to sub‐underwriters of the Retail Entitlement Offer.

Approximately 46.3 million New Shares to be issued under the Retail Entitlement Offer are expected to be allotted on Tuesday, 4 January 2022 and will trade on the ASX on a normal settlement basis on Wednesday, 5 January 2022. New Shares issued under the Retail Entitlement Offer will rank equally with existing Alcidion shares as at their date of issue. Holding statements are expected to be despatched on or around Wednesday, 5 January 2022.

Eligible retail shareholders should confirm the actual number of New Shares allocated and issued to them before trading in New Shares and the sale by any eligible retail shareholder of New Shares prior to receiving their holding statement is at their own risk.

This announcement is authorised for release on behalf of the board by the Company Secretary of Alcidion Group Limited.

‐‐ ENDS ‐‐

For further information, please contact:

Kerstin Wahlqvist

Investor Relations Manager Ph: +61 402 088 303 kerstin.wahlqvist@alcidion.com

Alcidion Group Limited | Level 10 9 Yarra Street SOUTH YARRA VIC 3141 |+61 3 8060 6177 | www.alcidion.com

==> picture [104 x 29] intentionally omitted <==

About Alcidion Group Limited (ASX:ALC)

Alcidion Group Limited (Alcidion) has a simple purpose: to transform healthcare with proactive, smart, intuitive technology solutions that improve the efficiency and quality of patient care in healthcare organisations, worldwide.

Alcidion offers a complementary set of software products and technical services that create a unique offering in the global healthcare market. Based on the flagship product, Miya Precision, the solutions aggregate meaningful information to centralised dashboards, support interoperability, facilitate communication and task management in clinical and operational settings and deliver Clinical Decision Support at the point of care; all in support of Alcidion’s mission to improve patient outcomes.

Since listing on the ASX in 2011, Alcidion has acquired multiple healthcare IT companies and expanded its foothold in the UK, Australia and New Zealand to now service over 300 hospitals and 60 healthcare organisations, with further geographical expansion planned.

With over 20 years of healthcare experience, Alcidion brings together the very best in technology and market knowledge to deliver solutions that make healthcare better for everyone.

www.alcidion.com

Page 2